Olympus opens new operational headquarters
Olympus Australia has moved its operational headquarters to a state-of-the-art facility in Melbourne that incorporates a fully operational customer experience centre, comprehensive training facilities and the company’s national service centre.
Olympus is a manufacturer and distributor of optical, electronic and precision engineering products for scientific, medical and industrial applications. Customers visiting the facility will be able to experience the complete range of these products in the various rooms dedicated to each of the company’s portfolios.
Industrial business division customers will have hands-on access to products utilised in non-destructive testing, remote visual inspection, materials analysis by X-ray fluorescence and high-speed imaging. Similar demonstration and training areas are available to digital photography and microscopy customers.
For medical imaging customers, the building has multiple training rooms, including a fully equipped operating theatre and an endoscopy room. All the medical systems are integrated utilising the latest control software which allows direct and remote control and monitoring of any piece of equipment.
On the floor below the customer experience centre is the national service centre, where cleanroom conditions have been established to disinfect, assess, repair and quality control the maintenance and upgrading of all instruments, including medical imaging equipment such as endoscopes and other medical devices.
Les Dick, CEO of the Australian Institute for Non-Destructive Testing (AINDT), described the building as “stunning”.
“In the past, AINDT has collaborated with Olympus to present specialised training seminars,” he noted, “and we look forward to bringing our members to this new facility and allowing them to gain hands-on experience of the latest technology.”
2024 GSK Award recognises neurodegeneration researcher
Professor Matthew Kiernan won the 2024 GSK Award for Research Excellence for his work in...
ACCC concerned by Blackstone's proposed acquisition of I'rom
The ACCC is concerned that the proposed acquisition would likely have the effect of substantially...
Publication of new standards for clinical trial data reuse
The standards aim to facilitate the responsible sharing and use of anonymised individual patient...